Article info
PDFBiochemical genetics
Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing
- Correspondence to Professor Silvère M van der Maarel, Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; S.M.van_der_Maarel{at}lumc.nl
Citation
Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing
Publication history
- Received June 27, 2019
- Revised September 4, 2019
- Accepted September 21, 2019
- First published November 1, 2019.
Online issue publication
November 27, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.